DPP-4 inhibitors

Carolyn F. Deacon

doi:10.1007/978-3-319-08982-9_4

DPP-4 inhibitors

Carolyn F. Deacon

Endocrinology and Metabolism

Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Communication

1 Citation (Scopus)

Abstract

Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.

Original language	English
Title of host publication	Handbook of incretin therapies in type 2 diabetes
Editors	S Gough
Place of Publication	Switzerland
Publisher	Springer
Publication date	2016
Pages	45-60
Chapter	4
ISBN (Print)	978-3-319-08981-2
ISBN (Electronic)	978-3-319-08982-9
DOIs	https://doi.org/10.1007/978-3-319-08982-9_4
Publication status	Published - 2016

Access to Document

10.1007/978-3-319-08982-9_4

Library access?

Check availability at the Royal Danish Library

Cite this

@inbook{3b4767c63bb2494ba25d8eab451cf56e,

title = "DPP-4 inhibitors",

abstract = "Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.",

author = "Deacon, {Carolyn F.}",

year = "2016",

doi = "10.1007/978-3-319-08982-9_4",

language = "English",

isbn = "978-3-319-08981-2",

pages = "45--60",

editor = "S Gough",

booktitle = "Handbook of incretin therapies in type 2 diabetes",

publisher = "Springer",

address = "Switzerland",

}

TY - CHAP

T1 - DPP-4 inhibitors

AU - Deacon, Carolyn F.

PY - 2016

Y1 - 2016

N2 - Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.

AB - Dipeptidyl peptidase (DPP)-4 inhibitors inhibit the activity of the enzyme responsible for the initial rapid degradation of the incretin hormones, thereby enhancing their antihyperglycemic effects.

U2 - 10.1007/978-3-319-08982-9_4

DO - 10.1007/978-3-319-08982-9_4

M3 - Book chapter

SN - 978-3-319-08981-2

SP - 45

EP - 60

BT - Handbook of incretin therapies in type 2 diabetes

A2 - Gough, S

PB - Springer

CY - Switzerland

ER -